 ORLANDO, FL ACCESSWIRE October 1, 2021 Nutriband Inc. NASDAQ:NTRB NASDAQ:NTRBW, a company engaged in the development of pharmaceutical products focused on preventing opioid abuse, contract research and development services and the contract manufacturing of topical and transdermal products, today announced that its common stock and warrants will begin trading on the Nasdaq Capital Market effective October 1, 2021. Nutriband also announced the pricing of an underwritten public offering of 1,056,000 units of securities at a public offering price of 6.25 per unit for total gross proceeds of 6.6 million, before deducting underwriting discounts and commissions and other estimated offering expenses. 